common.study.topics.clinical

Allogeneic Skin Grafting

common.study.values.description

Allogeneic Skin Grafting

The primary study objective is to evaluate local response to split-thickness skin grafts from a matched bone marrow donor to chronic GVHD-affected skin in a hematopoietic stem cell transplant patient.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - CelluTome® Epidermal Harvesting System

split-thickness skin grafts from a matched bone marrow donor using the CelluTome® Epidermal Harvesting System

participant.views.study.view.additional

participant.views.study.view.scientific-title

Allogeneic Skin Grafting in the Treatment of Chronic Cutaneous Graft-versus-host Disease: a Pilot Study

common.study.values.clinical-trial-id

NCT04015947

participant.views.study.view.id

epYDVa